TPD & Induced Proximity Summit Leaderboard
  • Sunday, August 2, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 829

Author

Pharma Journalist 8978 posts 0 comments

Adents obtains gateway provider certification from EMVO

Aug 16, 2017
After a series of thorough tests with the European Medicines Verification Organization (EMVO) for connection to the European Hub, Adents is now one of only two official “Certified…
Read More...

Array BioPharma Appoints Curtis Oltmans As General Counsel

Aug 16, 2017
Array BioPharma, a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer,…
Read More...

Oxford BioMedica announces a £2 million two-year collaboration co-funded by Innovate UK

Aug 16, 2017
A new consortium, led by Oxford BioMedica, will take part in a two-year, £2m project focused on gene and cell therapy manufacturing. Other partners include the Cell and Gene…
Read More...

Takeda Announces Alliance with Stanford University to Drive Therapeutic Discoveries

Aug 15, 2017
Takeda Pharmaceutical Company Limited announced a collaboration with Stanford University to form the Stanford Alliance for Innovative Medicines (Stanford AIM), which will help transform…
Read More...

PharmaMar Starts a Quadruple Combination Study With Aplidin for the Treatment of Multiple Myeloma

Aug 10, 2017
PharmaMar announced the start of a multicenter quadruple combination clinical study with Aplidin (plitidepsina), along with other compounds for the treatment of multiple myeloma.…
Read More...

Soin Neuroscience Signs Drug Development Deal for Non Addicting Pain Killer

Aug 10, 2017
Soin Neuroscience, a biotech startup based in Dayton, OH, has recently signed a drug development deal with Cleveland Diabetes Care for SNI's lead developmental pain drug TV1001SR- which…
Read More...

Avara Pharmaceutical Services acquires Sterile facility from Pfizer in Italy

Aug 9, 2017
Avara Pharmaceutical Services has signed an agreement with Pfizer Inc. to acquire the Liscate, Italy sterile manufacturing facility. "This acquisition is an important component of our…
Read More...

HitGen and LEO Pharma Enter Research Collaboration

Aug 8, 2017
HitGen Ltd announced that the company has entered into a multi-target multi-year collaboration with LEO Pharma A/S , to discover novel small molecule leads for multiple therapeutic…
Read More...

Charles River Laboratories Acquires Brains On-Line

Aug 8, 2017
Charles River Laboratories International, Inc. announced that it has acquired Brains On-Line, a leading contract research organization (CRO) providing critical data that advances novel…
Read More...

Nexus Pharmaceuticals Receives FDA Approval for Isoproterenol Hydrochloride Injection USP

Aug 6, 2017
Nexus Pharmaceuticals announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Isoproterenol…
Read More...
Prev Next
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Raw Materials for Cell & Gene Therapy Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • miRecule, EMS Unit Partner on RNA Delivery Technologies
  • Pfizer Reports Positive Phase 3 Results for LITFULO in Vitiligo
  • Resilience Expands Lilly Partnership With $750 Million Ohio Investmen
  • AbCellera, Vertex Partner on T-Cell Engagers for Autoimmune Diseases
  • EVERSANA to Commercialize Innovacell’s ICEF15 in the US

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

From Innovation to Acquisition: CrossBridge Bio’s ADC…

COPD Foundations Joins the COPD Drug Development Summit

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.